Literature DB >> 3024798

DNA flow analysis of soft tissue tumors.

A Kreicbergs, B Tribukait, J Willems, H C Bauer.   

Abstract

The cellular DNA content of 81 soft tissue tumors was determined by means of flow cytometry and related to conventional histologic classification of the same tumors. Comparison of histologic and cytometric analysis showed that all 23 benign tumors were diploid (normal DNA content), whereas the malignant group included both diploid and aneuploid (abnormal DNA content) lesions. There appeared to be a relationship between tumor grade and ploidy level in that 92% of Grade II, 28% of Grade III, and 11% of Grade IV lesions were diploid. Cell distribution analysis, feasible in 51 cases, disclosed that diploid lesions had a low proportion of S and G2 + M cells and most aneuploid lesions a high proportion, indicating a relationship between ploidy level and proliferative activity. The current study shows that solid mesenchymal tumors may be analyzed by DNA flow cytometry. Regardless of histogenetic type, it appears that benign and low-grade tumors are diploid and high-grade tumors, in general, are aneuploid. As to exceptions, DNA analysis may prove to give information beyond that obtained by subjective histologic interpretation. Thus, adequate follow-up might show that high-grade lesions with a diploid DNA content are associated with a better prognosis than expected from histologic classification.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3024798     DOI: 10.1002/1097-0142(19870101)59:1<128::aid-cncr2820590126>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients.

Authors:  Jan L M A Gielen; Arthur M De Schepper; Filip Vanhoenacker; Paul M Parizel; Xiaoling L Wang; Raf Sciot; Joost Weyler
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors.

Authors:  F W Spaar; U Spaar
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

4.  Extraspinal ependymoma in the sacrococcygeal region. A case report with ultrastructural, immunohistochemical and cytophotometric studies.

Authors:  Z Sápi; J Megyesi; I Besznyák; J Sugár
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Assessing prognosis for high-grade soft-tissue sarcomas: search for a marker.

Authors:  X Q Li; S G Parkekh; A E Rosenberg; H J Mankin
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

6.  Epithelioid sarcoma: an electron-microscopic, immunohistochemical and DNA flow cytometric analysis.

Authors:  T Ishida; T Oka; H Matsushita; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.

Authors:  P Korkolopoulou; P Christodoulou; A Papanikolaou; A Tsenga; E Thomas-Tsagli
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Alveolar soft part sarcoma. An immunohistochemical, cytologic and electron-microscopic study and a quantitative DNA analysis.

Authors:  S Persson; J S Willems; L G Kindblom; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Prognostic relevance of DNA content in childhood renal tumours.

Authors:  S Kumar; H B Marsden; R A Cowan; J M Barnes
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas.

Authors:  M Samur; A Pamir; H Akbulut; S Erekul; Y Sağlik; Y Yildiz; D Dinçol; F Içli
Journal:  Sarcoma       Date:  1999
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.